For decades, conventional thinking has championed the idea that oxidative stress -the internal and external factors that give rise to oxidative damage to cellular proteins, membranes, and DNA -was "bad", serving as the rationale for using dietary supplemendisease. Yet, even today, the precise role of reactive oxygen species (ROS) in most human diseases remains mostly unknown [1, 2] . In some instances, elevated markers of oxidative damage may merely correlate with pathology, rather than be causative. Antioxidant in-cant impact on disease outcomes. Methodological shortcomings encountered in the measurement of ROS production and oxidative damages need to be meticulously addressed so that sound conclusions can be drawn from the burgeoning number of clinical and mechanistic studies [1] .
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A deepening of our understanding of the role of ROS in human disease will require drawing our attention to how ROS operate within a vast number of distinctive physiological contexts. What is needed are conceptual frameworks that will enable us to move beyond generalized, monolithic statements, such as "Oxidative stress is bad", because these statements may distort or conceal the benterms introduced by Helmut Sies [3] to distinguish between conditions of physiological reduction-oxidation (redox) signaling (oxidative eustress) and conditions of disrupted redox signaling and oxidative damage (oxidative distress) serve as an example of such an explanatory framework. What emerges from this kind of dual thinking is an appreciation for the potential importance of redox- 
The concept of redox homeostasis
Growing evidence indicates the essential role that ROS plays in regulating a wide range of biological phenomena [2, 4] . Reactive oxygen species -once clearly ear-marked as the villainous contributor to cell damages -are now being seen in a different light.
The previously satisfying view of chaotic, dysregulated ROS production leading to the damage of everything in its wake has given way to a richer picture of biological complexity. Tightly-regulated ROS production (particularly hydrogen peroxide, H 2 O 2 ) along with tightly-regulated systems dedicated to H 2 O 2 removal contribute to redox homeostasis. To maintain intracellular redox state within these workable limits, cells are dynamically equipped to respond or adapt to changes in their redox state, including critical spatiotemporal variations in the concentration of oxidants and reductants.
Some of the key players contributing to redox homeostasis are chain of mitochondria as a by-product of cellular respiration and ATP production. ROS are also produced by a group of professional ROS-generating enzymes called NADPH oxidases (NOX) [3, 5] 
Tuberculosis (TB)
Tuberculosis is a leading cause of mortality world-wide [16] .
The disease occurs in susceptible persons exposed to a bacterium (most commonly Mycobacterium tuberculosis, Mtb) leading to pathologic damage of lung and other tissues. As infection proceeds, Mtb replicates within host macrophages. In response to the invading pathogen, tissue macrophages initiate a respiratory burst, producing high levels of ROS and nitric oxide in an attempt to eradicate the bacteria [17] . Not surprisingly, Mtb has co-evolved extensive systems to maintain its own intracellular redox balance, enabling the pathogen to survive and replicate within hostile host macrophages [18] . Prolonged (6 months) drug treatment can be effecrifampin) has increasingly become a threat to global health [19] .
But treatment failure in TB is not limited to the acquisition of multiple drug resistance. Mtb can evade drug killing by assuming a state of metabolic dormancy [20] . The dormant state of these "persister cells" is characterized by low cellular respiration, low ROS production, and resistance to bactericidal antibiotics. Could the manipulation of cellular respiration [21] in drug-insensitive persistent Mtb serve as a pro-oxidant strategy that would lead to eradication of dormant bacteria? The rationale for pursuing this kind of approach is strengthened further by the discovery that although Mtb is endowed with robust defenses against exogenous oxidative assaults by host macrophages, Mtb is highly sensitive to perturbations in Reactive oxygen species differ in their capacity to damage macromolecules and to serve as signaling moieties. Superoxide anion generated by mitochondria and by NOX is readily converted by superoxide dismutase (SOD) to H 2 O 2 . By removing superoxide anion, the cell is protected from the generation of hydroxyl radical (OH . ), a highly reactive, toxic species for which cells have evolved no enzymatic systems to eliminate. Pharmacologic concentrations of the ROS scavenger vitamin C can exert pro-oxidant effects, serving as a prodrug for the formation of H 2 O 2 in the extracellular space [6] . [27] . Remarkable advances in the use of combination antiretroviral therapy (referred to as cART or HAART) can effectively suppress HIV viral load, saving lives, but cannot completely eliminate transcriptionally inactive (latent) viral reservoirs. Among the current challenges facing interventionalists is how to eradicate these latent HIV reservoirs [28] and how to minimize the adverse consequences of chronic immune activation, such as the elevated risk for chronic, non-communicable diseases that occurs among HIV treatment responders [29] .
Redox alterations associated with HIV infection have been ex-
tensively catalogued, with one review concluding that "HIV infection leads to pronounced oxidative stress" [30] . Recently, investigators are turning to new classes of anti-HIV compounds that target the patient's redox-regulating enzyme thioredoxin reductase-1 (TrxR1). But the aim of this approach is not augmentation of TrxR1 activity, but rather inhibition.
Cancer metastasis
Cancer metastasis is the multi-step process by which cancer cells escape the primary tumor to establish deposits in distant locations within the body. Metastasis, not the local effects of primary tumor growth, accounts for the vast majority of cancer-attributable gaining access to the systemic circulation are capable of successfully establishing a tumor metastasis in the foreign soil of a distant target organ [36] .
The use of antioxidants to reduce the risk of cancer development has been proposed and large-scale prevention trials have been conducted with few favorable results [37, 38] . However, a study published in by Piskounova., et al. [39] has provided a closer appraisal of the redox context of cancer cells. The results of
HIV
The rationale behind this partially unexpected approach stems from the observation that the entry of HIV-1 into host cells is a redox-sensitive event [31] tial role in HIV-1 entry into CD4+ T lymphocytes. The Trx-1 -TrxR1 gp120 viral envelope protein of HIV. Failure of this reducing activity results in conformational changes in gp120 that prohibit fusion of host cell membranes and viral membranes. The gold-containing the agents that have been shown to block HIV entry using this prooxidative TrxR1 -inhibiting approach [32] .
Since central and transitional memory T cells serve as a major reservoir for transcriptionally inactive virus in cART treated patients, approaches are being pursued to selectively remove these potent inhibitor of thioredoxin reductases, was shown to have bensubsets, presumably by exploiting the already lower baseline antioxidant defenses of these cells compared to naïve T lymphocytes [33] nine sulfoximine (BSO) combinations have been demonstrated in a simian model of HIV [34] . The rationale for using this dual targeting combination is that BSO, a selective inhibitor of glutathione depleting intracellular glutathione [35] . The suggestion that the establishment and persistence of HIV reservoirs may be redox sensitive and therefore susceptible to pro-oxidant targeting requires further investigation.
endogenous ROS levels [22] .
Investigators are now studying closely the redox context that supports Mtb persistence. Recent in vitro studies by Vilchèze., et al. [23] have shown that administering small thiols (e.g. cysteine)
to In separate work using mouse xenograft models, antioxidant antidiabetic agents increased cancer metastasis, without affecting the incidence of tumor formation [40] . Consistent with the work cited above, those agents that activated Nrf2 -one of the prime pathways used to upregulate antioxidant defenses -had the most potent metastasis-promoting effect. These results were subseoverexpression or pharmacological upregulation of Nrf2 increased the ability of cancer cells to migrate and metastasize [40] . Taken together, the results suggest that the preferred choice of antioxidant versus pro-oxidant strategies may differ in cancer chemopreventive versus cancer treatment settings [41] .
Synthesis
need for nuanced approaches, the kind of approaches that incite completely the role of ROS in health and disease.
